Display options
Share it on

J Oncol. 2012;2012:905024. doi: 10.1155/2012/905024. Epub 2011 Dec 22.

Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System.

Journal of oncology

Anja Gulliksen, Helen Keegan, Cara Martin, John O'Leary, Lars A Solli, Inger Marie Falang, Petter Grønn, Aina Karlgård, Michal M Mielnik, Ib-Rune Johansen, Terje R Tofteberg, Tobias Baier, Rainer Gransee, Klaus Drese, Thomas Hansen-Hagge, Lutz Riegger, Peter Koltay, Roland Zengerle, Frank Karlsen, Dag Ausen, Liv Furuberg

Affiliations

  1. NorChip AS, Industriveien 8, 3490 Klokkarstua, Norway.

PMID: 22235204 PMCID: PMC3253481 DOI: 10.1155/2012/905024

Abstract

The paper presents the development of a "proof-of-principle" hands-free and self-contained diagnostic platform for detection of human papillomavirus (HPV) E6/E7 mRNA in clinical specimens. The automated platform performs chip-based sample preconcentration, nucleic acid extraction, amplification, and real-time fluorescent detection with minimal user interfacing. It consists of two modular prototypes, one for sample preparation and one for amplification and detection; however, a common interface is available to facilitate later integration into one single module. Nucleic acid extracts (n = 28) from cervical cytology specimens extracted on the sample preparation chip were tested using the PreTect HPV-Proofer and achieved an overall detection rate for HPV across all dilutions of 50%-85.7%. A subset of 6 clinical samples extracted on the sample preparation chip module was chosen for complete validation on the NASBA chip module. For 4 of the samples, a 100% amplification for HPV 16 or 33 was obtained at the 1 : 10 dilution for microfluidic channels that filled correctly. The modules of a "sample-in, answer-out" diagnostic platform have been demonstrated from clinical sample input through sample preparation, amplification and final detection.

References

  1. Nature. 1991 Mar 7;350(6313):91-2 - PubMed
  2. Lab Chip. 2007 Jan;7(1):41-57 - PubMed
  3. Anal Chem. 2004 Jan 1;76(1):9-14 - PubMed
  4. Lab Chip. 2009 Dec 7;9(23):3399-405 - PubMed
  5. PLoS One. 2010 Sep 13;5(9):e12724 - PubMed
  6. Lab Chip. 2001 Dec;1(2):83-95 - PubMed
  7. J Virol Methods. 2009 Jan;155(1):61-6 - PubMed
  8. Ann N Y Acad Sci. 2007 Mar;1098:429-36 - PubMed
  9. Nucleic Acids Res. 2007;35(13):4223-37 - PubMed
  10. Chem Soc Rev. 2010 Mar;39(3):1153-82 - PubMed
  11. Br J Cancer. 2010 Mar 16;102(6):957-65 - PubMed
  12. Nature. 2006 Jul 27;442(7101):412-8 - PubMed
  13. J Med Virol. 2004 May;73(1):65-70 - PubMed
  14. Analyst. 2010 Sep;135(9):2408-14 - PubMed
  15. Biomed Microdevices. 2010 Dec;12(6):1043-9 - PubMed
  16. Annu Rev Biomed Eng. 2008;10:107-44 - PubMed
  17. J Clin Microbiol. 2006 Apr;44(4):1310-7 - PubMed
  18. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
  19. J Clin Microbiol. 1990 Mar;28(3):495-503 - PubMed
  20. Nat Rev Cancer. 2002 May;2(5):342-50 - PubMed
  21. Int J Cancer. 2005 May 10;114(6):973-6 - PubMed
  22. Clin Chim Acta. 2002 Jul;321(1-2):1-10 - PubMed
  23. J Virol Methods. 2010 Oct;169(1):219-22 - PubMed
  24. Lab Chip. 2008 Dec;8(12):2071-8 - PubMed
  25. Lab Chip. 2005 Apr;5(4):416-20 - PubMed

Publication Types